Sustainable Insight Capital Management LLC purchased a new position in UnitedHealth Group Inc (NYSE:UNH) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 1,100 shares of the healthcare conglomerate’s stock, valued at approximately $268,000.
A number of other hedge funds also recently added to or reduced their stakes in the business. Parkside Financial Bank & Trust grew its stake in UnitedHealth Group by 4.2% in the 2nd quarter. Parkside Financial Bank & Trust now owns 1,628 shares of the healthcare conglomerate’s stock worth $397,000 after buying an additional 65 shares in the last quarter. Mycio Wealth Partners LLC purchased a new stake in shares of UnitedHealth Group in the 2nd quarter valued at $1,092,000. West Branch Capital LLC boosted its stake in shares of UnitedHealth Group by 7.9% in the 2nd quarter. West Branch Capital LLC now owns 7,058 shares of the healthcare conglomerate’s stock valued at $1,722,000 after purchasing an additional 516 shares in the last quarter. Great Lakes Advisors LLC boosted its stake in shares of UnitedHealth Group by 12.1% in the 2nd quarter. Great Lakes Advisors LLC now owns 255,982 shares of the healthcare conglomerate’s stock valued at $62,462,000 after purchasing an additional 27,550 shares in the last quarter. Finally, PFG Advisors boosted its stake in shares of UnitedHealth Group by 1.0% in the 2nd quarter. PFG Advisors now owns 4,866 shares of the healthcare conglomerate’s stock valued at $1,231,000 after purchasing an additional 50 shares in the last quarter. 85.37% of the stock is owned by institutional investors and hedge funds.
UNH traded down $4.11 during trading on Thursday, hitting $236.24. 164,921 shares of the stock traded hands, compared to its average volume of 3,151,811. The firm has a market capitalization of $231.91 billion, a P/E ratio of 18.35, a price-to-earnings-growth ratio of 1.30 and a beta of 0.61. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.67 and a quick ratio of 0.67. The firm has a 50-day moving average of $251.29 and a 200 day moving average of $247.40. UnitedHealth Group Inc has a 12-month low of $208.07 and a 12-month high of $287.94.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $3.46 by $0.14. The business had revenue of $60.60 billion during the quarter, compared to analysts’ expectations of $60.59 billion. UnitedHealth Group had a net margin of 5.51% and a return on equity of 25.20%. The firm’s revenue for the quarter was up 8.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $3.14 EPS. As a group, equities analysts predict that UnitedHealth Group Inc will post 14.84 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be issued a $1.08 dividend. The ex-dividend date is Friday, September 13th. This represents a $4.32 annualized dividend and a yield of 1.83%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.54%.
In other UnitedHealth Group news, Director Richard T. Burke sold 10,000 shares of the company’s stock in a transaction on Tuesday, June 11th. The shares were sold at an average price of $248.00, for a total value of $2,480,000.00. Following the completion of the transaction, the director now directly owns 187,663 shares in the company, valued at approximately $46,540,424. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Richard T. Burke sold 5,000 shares of the company’s stock in a transaction on Thursday, August 8th. The stock was sold at an average price of $246.40, for a total transaction of $1,232,000.00. Following the completion of the transaction, the director now owns 187,979 shares of the company’s stock, valued at $46,318,025.60. The disclosure for this sale can be found here. Insiders sold a total of 37,000 shares of company stock valued at $9,195,620 over the last 90 days. Company insiders own 0.87% of the company’s stock.
A number of equities research analysts have recently issued reports on UNH shares. Cleveland Research reaffirmed a “buy” rating on shares of UnitedHealth Group in a research note on Monday, July 15th. Citigroup raised shares of UnitedHealth Group from a “neutral” rating to a “buy” rating and upped their price objective for the company from $247.00 to $280.00 in a research note on Friday, May 10th. Morgan Stanley upped their price objective on shares of UnitedHealth Group from $285.00 to $298.00 and gave the company an “overweight” rating in a research note on Friday, July 12th. Zacks Investment Research raised shares of UnitedHealth Group from a “sell” rating to a “buy” rating and set a $269.00 price objective for the company in a research note on Monday, July 22nd. Finally, Oppenheimer set a $312.00 price objective on shares of UnitedHealth Group and gave the company a “buy” rating in a research note on Friday, July 19th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and eighteen have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $295.06.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.